Decreased topoisomerase IIα expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells
- 1 May 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 166 (1) , 71-77
- https://doi.org/10.1016/s0304-3835(01)00447-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health and Welfare
This publication has 16 references indexed in Scilit:
- A Novel Mechanism of Cell Killing by Anti-topoisomerase II BisdioxopiperazinesJournal of Biological Chemistry, 2000
- Structural organization of the human TOP2A and TOP2B genesGene, 1998
- Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agentsCancer Chemotherapy and Pharmacology, 1998
- Antitopoisomerase drug action and resistancePublished by Elsevier ,1996
- Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cellsMutation Research/DNA Repair, 1996
- Antitumor bisdioxopiperazines inhibit yeast DNAtopoisomerase II by trapping the enzyme in the form of a closed proteinclamp.Proceedings of the National Academy of Sciences, 1994
- Mutant isolation of mouse DNA topoisomerase llα in yeastNucleic Acids Research, 1994
- Characterization of cDNA encoding the mouse DNA topoisomerase II that can complement the budding yeasttop2mutationNucleic Acids Research, 1992
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987